{"name":"Viatris Inc.","slug":"viatris-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1953-01-01","label":"Phenytoin Sodium first approved","drug":"Phenytoin Sodium","drugSlug":"phenytoin","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Cardura first approved","drug":"Cardura","drugSlug":"doxazosin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"ACT-246475","genericName":"ACT-246475","slug":"act-246475","indication":"Other","status":"phase_1"},{"name":"diazepam 20 mg","genericName":"diazepam 20 mg","slug":"diazepam-20-mg","indication":"Other","status":"marketed"},{"name":"AC-076 for s.c. administration","genericName":"AC-076 for s.c. administration","slug":"ac-076-for-s-c-administration","indication":"Other","status":"phase_1"},{"name":"Dovprela","genericName":"Dovprela","slug":"dovprela","indication":"Other","status":"phase_2"},{"name":"gabapentin 600 mg","genericName":"gabapentin 600 mg","slug":"gabapentin-600-mg","indication":"Other","status":"marketed"},{"name":"pregabalin 450 mg","genericName":"pregabalin 450 mg","slug":"pregabalin-450-mg","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Phenytoin Sodium","genericName":"PHENYTOIN","slug":"phenytoin","indication":"Bipolar disorder in remission","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Cardura","genericName":"DOXAZOSIN","slug":"doxazosin","indication":"Benign prostatic hyperplasia","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"MR-107A-02","genericName":"MR-107A-02","slug":"mr-107a-02","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"ACT-246475","genericName":"ACT-246475","slug":"act-246475","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Phenytoin Sodium","genericName":"PHENYTOIN","slug":"phenytoin","phase":"marketed","mechanism":"Phenytoin Sodium works by stabilizing the threshold against hyperexcitability caused by excessive stimulation.","indications":["Bipolar disorder in remission","Epilepsy","Epilepsy characterized by intractable complex partial seizures","Lennox-Gastaut syndrome","Localization-related epilepsy"],"catalyst":""},{"name":"Cardura","genericName":"DOXAZOSIN","slug":"doxazosin","phase":"marketed","mechanism":"Alpha-1B adrenergic receptor","indications":["Benign prostatic hyperplasia","Hypertensive disorder"],"catalyst":""},{"name":"diazepam 20 mg","genericName":"diazepam 20 mg","slug":"diazepam-20-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-076 for s.c. administration","genericName":"AC-076 for s.c. administration","slug":"ac-076-for-s-c-administration","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dovprela","genericName":"Dovprela","slug":"dovprela","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MR-107A-02","genericName":"MR-107A-02","slug":"mr-107a-02","phase":"phase_3","mechanism":"MR-107A-02 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"gabapentin 600 mg","genericName":"gabapentin 600 mg","slug":"gabapentin-600-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"pregabalin 450 mg","genericName":"pregabalin 450 mg","slug":"pregabalin-450-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOb0hQcFRDYVM4VHJpQzJCTGhMb1V0UGtOSzdsbzBKZ09tXzhCU0l4M3kzaGJaOVZtakQycDBNMUZmS0d1cERKQ0JPTnE4bWFxQU9XLTNxQVNNTldFcWJoXzdHSWF4Vmt6eUI4WDYxYTBlOGM1d25nSGR3ZTNiX0tvd1J2TUFycTlPcHRzS0xPWHFOZ0YyeVpTQzJCMGxiM2ljeElEbGlualVDbGNGdG1rZmZR?oc=5","date":"2026-03-23","type":"regulatory","source":"Contract Pharma","summary":"Viatris’ Effexor Approved in Japan for Generalized Anxiety Disorder - Contract Pharma","headline":"Viatris’ Effexor Approved in Japan for Generalized Anxiety Disorder","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQTkdmZXVYU2Z6WjhsM0pldWtaa0xUeVBWaTlZSjFNYnFPbkliVHMzZGNxRFp3T3lkdnJiOVZSYU1xVnZyallvMVg0SERhY2sxNFRmeUZ1ZTVkS2pzenpYUGJKbnlZd3dpVGlxNnBIdk5HWFVZaWgtS2diMmVJcHQzbzd0dVp5YkRwNlh3bHZhSFFNamlSTTFDbUR3ZzJwOHZQX3FTekpNRndncmV1VFhhUGVBbnJOM1p2TjNpZDFscnNrNG45dkZpdmtST3lzVnVMRlJyalRNbnFpcENIN3ZJ?oc=5","date":"2026-03-13","type":"pipeline","source":"Reuters","summary":"Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research - Reuters","headline":"Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPS0dNaVdURDdrOWZjTHBmd29reXVNZGY1MHlOaXMxeG9aN2lIZkM0a2Vrb1RYQ0phN1JZeE1ONUx5eWFhYjNSTU05VjFqVkZzb0F3V0M4UExXZllvelo4cS1VcUxGOFQ2N3BhTVN4VVdVVlRGbktJZVpPUTJ0c1g4N1g2UzNmTTdQX1FyQUthajVKT3RlcjFN0gFWQVVfeXFMUG5LNlZFRE0wNnVpOFE5Y2dwM2llbU44blZwbllXWkxzZjZyNkpkWXNiYzd6WWpSOWdlXzJRbjB3bHp6dmNQbVhWY1RCbXVZTDVma3dOTFE?oc=5","date":"2026-03-04","type":"patent","source":"Law360","summary":"Viatris Unit Can't Ax Patent For Anemia Drug Evrenzo - Law360","headline":"Viatris Unit Can't Ax Patent For Anemia Drug Evrenzo - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOQ0FjNHB1VWh0TWhqVWtNa3ZjYWttZlNBNkM1bGRiUHNOZjZvVktrRjY2a194Qkh3WHdSbDBDeEJoUDNKSXdWLThhWjgzZEhjczctQUhiOE1heTdvb0g1WkpwLUNVSW1fSW56NXpPaWFUWDNjS3RQTE1tX1lwZEZYVjI5SHhZaHNGS3BRRldBYzAtdjMzWHBOWktqalFhMTdoMU0tcFVJeVEwd0pL?oc=5","date":"2026-03-02","type":"earnings","source":"finviz.com","summary":"Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4 - finviz.com","headline":"Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQZHh2ZUtUcHVEZTVHY3U1WHpEczR4QXJiN280dzdINThSSWJmOUlxNlRQTHZfaG1teEZUM2x0eHVWRHRsVUF6TkZ6VVNpOW1YOU9ISjdMc3FvcW9DVkhNeHloUFc0MERoZEkzeV9CNXltYngtdWM4RlB2anF5Vk5pZEpvcjM3eF9ZNmFSQ2g5ZTBnUWducThRUUhOeDVMUFMzNmZYemh4NXFRS3l6a0lBUjM5TE4wYlFhUVBISGs5bUgtZEVjUF9kVjZqVkVQWWVndTBDSnpn?oc=5","date":"2026-02-26","type":"pipeline","source":"Pittsburgh Post-Gazette","summary":"Restructuring: Viatris to cut global workforce by about 10% - Pittsburgh Post-Gazette","headline":"Restructuring: Viatris to cut global workforce by about 10% - Pittsburgh Post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPOUlxZjB4cG1wSmpjSWZyNU8zaDdSZVdmaHlUNnpaVnR0WTJBWHlSYVRCZnJSa1JobjVvLWktREJ0TnhnYzZ2U3NvblFpUW5jdF9pYm9hNlk0TGlrVEVpaE5vblVMbWR2b25uXzhPZzFCZmtRcUpiVDc3RFFWaXNhZDlPYkI4RlVJZ1lYYVA5U0J0OGN4Y1FhbWdFZ0lkMmg3OHpIbUk3RXhJaEIwanFv?oc=5","date":"2026-02-26","type":"pipeline","source":"Fierce Pharma","summary":"Viatris to cut 10% of workforce in 3-year overhaul, discloses fire at India plant - Fierce Pharma","headline":"Viatris to cut 10% of workforce in 3-year overhaul, discloses fire at India plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOSmtmT1Q4eW82WWVMbUVqVTl0Wkdfa09BaEpqaHNob0JTZHAwWTZGTy0xdlJOTVF1bnFIdE1CaDdTTFBCV2JHa1VPQ0hHVU5JYTJNblF5T1hGWk9qVUxxdXZGTFZHMHdUcklqX3BNNVd4ZlBiUldUSDV5dndoRVhjNjhwVmEzUVVkRWRuV1FCMTd4VFBhOWxGbDV3WEtSVHNpc01mMGN6NVNwTTloYm9zaQ?oc=5","date":"2026-02-23","type":"earnings","source":"TradingView","summary":"Viatris Stock to Report Q4 Earnings: What's in the Cards? - TradingView","headline":"Viatris Stock to Report Q4 Earnings: What's in the Cards?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUHZGaHdhMWNZa2thRXFQdlEySVJjTEtkM3MzakxxZFVrNGYySE9aMGpONElnaDhSOHpvUlNZNl84RkdpT0FBb0hLaG1JUmpORXJZWWx2ekl6VkZLMF9kZVhXN0dDRkpuZTdRcVl0UmVrLXJ2ZXIybElGTjh1dzBQMEZpZ2RLT0pOQk41UFBvMkx5NUdCRmNqenI5WVNyNjczeXdmMjY1ZmRrS25uUElSd01fclE0eEdhS3ROZ1NxUzZidw?oc=5","date":"2026-02-20","type":"pipeline","source":"seekingalpha.com","summary":"Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation - seekingalpha.com","headline":"Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZ3k4STJFRlJKX3NYSW85aXc4NC1aY25MN3VRVVgwVkJYWUNjTDRxcnBoWTh5Y1JIczJaNS1rSmtLRzk5MWxKTHBCWV9wUFdvVmZkbnF1cHc5TXBKbV9tajFHb05UZXBPYk1GQ0FUZnNWUFNvaENhR3ViVVE1a1B2S05mOGNxdnp0WThNazlPSWFnbEUwV1luckw1Y2FJeC1jNE1KZjhwcTBzaV9fd2lVaHFzVVY2eDBJQXhVM1lzUVNMdkVSUGdjMk5Tb3libDRrOHItR0s0dzdYTnRWQVJ4eThiQnA0dw?oc=5","date":"2026-02-10","type":"patent","source":"FinancialContent","summary":"Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse - FinancialContent","headline":"Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQbFhpYVg5UWdBbGFPMHhoQWpjSG54dXhYY3VVZzRMUEVOa01DZkd5ekZYeFpoVFp5QjEzcW1vQkFGbU9HUlpMaUVMclJtZFlVQTgxSTRyT3dFekNlelo1akkyTEc3MmotdTlFS3U2b1VFQXpMWGQ0Z2w2Q0pzRlpoR1AtTnJaQWZldEhNdFdQX1QtUQ?oc=5","date":"2025-12-30","type":"pipeline","source":"Yahoo Finance","summary":"Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves - Yahoo Finance","headline":"Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPd2ZMa1BZSHQtWTRGdnEyT1ZCODhic3JCa0xiVXhDRHlfaEt4YlFNLUFrOGc3VjEtMF85bzQ2U29FZnFXUExQRUZsaE94cGpETFk3dnlua0YtcXoxcDVCcGhpM1pkUEE2dy10M09aNmFTbm1vTGxreXMyYVVtd3M1MDdKeWc?oc=5","date":"2025-10-21","type":"deal","source":"Yahoo Finance","summary":"Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc - Yahoo Finance","headline":"Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxQa2xwOWxPQkVIQXRkbDB2RFJ1d2RwSm9TUmt3UTlMa0t0NEVJcXlGTFNyYWdKQVdFYktnZVkxRDhHVmNVbm9aU0w5RG5fQk9vdFF4OE4wNHBmZGtwc0tUeTJQT1l2aUMtd0l5czczTjRJaGtmby1rd1hjTFctLTFWTjZnNDNYdC1LdE9aRkJqRGd3NWxSeFJNdDlsd3pxaVFQZzJzNkhTQ2xnb3hNdy1ONGdwWEVjRVZ2Y1VKQVJkZ3UzeWR0eWltSEFoeV9wUGVFRmxodm9MT25sUF9hT3F1Wi1VVDhkLWtKbHJ4TWZmSUtvSFhZdnI2OFlTWW1vdFlYSDV2cXREYVJ2c1UteW9GUUQ1SW1hdDRmZTlQVXZxUl9kZ3hpSU82eGNkWW01ZU1SZ2JKT1gtQ1V4Tm8tLXBkQXFiN19FSEU2VHlnNQ?oc=5","date":"2025-10-15","type":"pipeline","source":"prnewswire.com","summary":"Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region - prnewswire.com","headline":"Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_1":2,"marketed":5,"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}